Jason Hoitt, Chief Commercial Officer at Dova Pharmaceuticals Inc. (DOVA), sold 7,580 shares at $15.10 ($116K) on 2019-07-15, disclosed to the SEC on 2019-07-16.
Open-market sale of $116k DOVA by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.10 | 6,680 | $101K | 87.2% |
| 2 | $16.44 | 900 | $15K | 12.8% |
| Total | $15.26 avg | 7,580 | $116K | 100% |
| Filing → |
| PRVB | BUY | 2020-03-20 | $24K | — | Filing → |
| DOVA | SELL | 2019-10-02 | $67K | — | Filing → |
| DOVA | SELL | 2019-07-02 | $33K | — | Filing → |